Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | PDE5A | O76074 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | CLPP | Q16740 | 1/20 | 0.34 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.34 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | DRD4 | P21917 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28980919 | 0.82 | KMT2A (0.46) | ALDH1A1CLPPPRMT5WDR77KDM4E | |
| SCHEMBL30337129 | 0.82 | KMT2A (0.46) | ALDH1A1CLPPPRMT5WDR77KDM4E | |
| SCHEMBL30337505 | 0.78 | ALDH1A1 (0.46) | ALDH1A1HTTCLPPPRMT5WDR77 | |
| SCHEMBL30337066 | 0.78 | FAAH (0.48) | — | |
| SCHEMBL30337569 | 0.74 | KDM4E (0.46) | HTR1AALDH1A1PDE5AHTTKDM4E | |
| SCHEMBL30337582 | 0.72 | SMN1; SMN2 (0.45) | HTR1A | |
| SCHEMBL30337300 | 0.72 | HTR1A (0.45) | HTR1AALDH1A1PDE5AKDM4E | |
| SCHEMBL30336976 | 0.70 | KMT2A (0.55) | HTR1ACLPPDRD4 | |
| SCHEMBL24938893 | 0.69 | CYP19A1 (0.43) | HTR1A | |
| SCHEMBL30337305 | 0.69 | HTR1A (0.43) | HTR1AALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115916206-A | Novel compound and pharmaceutical composition for preventing or treating resistant cancer comprising same | 治愈医药社株式会社 | 2023-04-04 | — | — | CN | disclosed |